Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma

被引：0
|
作者：
Wang, Li [1 ]
Zhang, Xin [2 ]
Lu, Yanrong [1 ]
Tian, Bole [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
GLAND SURGERY | 2021年 / 10卷 / 07期
关键词：
PREOPERATIVE CHEMORADIATION; MORBIDITY;
D O I：
10.21037/gs-21-379
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2340 / 2342
页数：3
相关论文
共 50 条
  • [21] Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma?
    Reni, Michele
    Macchini, Marina
    Orsi, Giulia
    [J]. JAMA ONCOLOGY, 2022, 8 (12) : 1851 - 1851
  • [22] Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy
    Shohei Takaichi
    Yoshito Tomimaru
    Shogo Kobayashi
    Keisuke Toya
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Takehiro Noda
    Hidenori Takahashi
    Tadafumi Asaoka
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    [J]. Annals of Surgical Oncology, 2023, 30 : 2458 - 2468
  • [23] Neoadjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer
    Lee, Sang Hoon
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 84 (03): : 103 - 110
  • [24] Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Bonds, Morgan
    Rocha, Flavio G.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [25] The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
    Kenji Kawahara
    Shigetsugu Takano
    Katsunori Furukawa
    Tsukasa Takayashiki
    Satoshi Kuboki
    Masayuki Ohtsuka
    [J]. Clinical & Experimental Metastasis, 2022, 39 : 311 - 322
  • [26] The role of systemic therapy in borderline resectable and locally advanced pancreatic ductal adenocarcinoma
    Lo, Victor C. K.
    Goodwin, Rachel A.
    Vickers, Michael M.
    [J]. JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [27] Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Satoi, S.
    Yamamoto, T.
    Uchida, K.
    Fujii, T.
    Kin, T.
    Asano, T.
    Hanada, K.
    Itoi, T.
    Murakami, Y.
    Igarashi, H.
    Eguchi, H.
    Kuroki, T.
    Shimizu, Y.
    Tani, M.
    Tanno, S.
    Tsuji, Y.
    Hirooka, Y.
    Masamune, A.
    Mizumoto, K.
    Shimokawa, T.
    Yamaue, H.
    Okazaki, K.
    [J]. PANCREAS, 2019, 48 (10) : 1516 - 1517
  • [28] The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma
    Kawahara, Kenji
    Takano, Shigetsugu
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Ohtsuka, Masayuki
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (02) : 311 - 322
  • [29] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma
    Kang, J.
    Kim, K-P.
    Yoo, C.
    Lee, J-L.
    Ryoo, B-Y.
    Chang, H-M.
    Lee, S. S.
    Park, D. H.
    Song, T. J.
    Seo, D. W.
    Lee, S. K.
    Kim, M-H.
    Hwang, D. W.
    Song, K. B.
    Lee, J. H.
    Kim, S. C.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [30] Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study
    Secanella, Luis
    Busquets, Juli
    Pelaez, Nuria
    Sorribas, Maria
    Laquente, Berta
    Ruiz, Sandra
    Carnaval, Thiago
    Videla, Sebastian
    Fabregat, Juan
    [J]. MEDICINE, 2022, 101 (48) : E32126
12345